Publications for Raymond J. Dattwyler raymond_dattwyler@nymc.edu
Arnaboldi, P. M., Sambir, M., D'Arco, C., Peters, L. A., Seegers, J. F., Mayer, L., . . . Dattwyler, R. J. (2016). Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Vaccine, 34(47), 5768-5776. doi:10.1016/j.vaccine.2016.09.063
Arnaboldi, P. M., Sambir, M., D'Arco, C., Peters, L. A., Seegers, J. F., Mayer, L., McCormick, A. A., & Dattwyler, R. J. (2016). Intranasal delivery of a protein subunit vaccine using a tobacco mosaic virus platform protects against pneumonic plague. Vaccine, 34(47), 5768-5776. doi:10.1016/j.vaccine.2016.09.063
Callister, S. M., Jobe, D. A., Stuparic-Stancic, A., Miyamasu, M., Boyle, J., Dattwyler, R. J., & Arnaboldi, P. M. (2016). Detection of IFN-γ secretion by T cells collected before and after successful treatment of early Lyme disease. Clinical Infectious Diseases, 62(10), 1235-1241. doi:10.1093/cid/ciw112
Arnaboldi, P. M. & Dattwyler, R. J. (2015). Cross-reactive epitopes in Borrelia burgdorferi p66. Clinical and Vaccine Immunology, 22(7), 840-843. doi:10.1128/CVI.00217-15
Lahey, L. J., Panas, M. W., Mao, R., Delanoy, M., Flanagan, J. J., Dattwyler, R. J., . . . Arnaboldi, P. M. (2015). Development of a multiantigen panel for improved detection of Borrelia burgdorferi infection in early Lyme disease. Journal of Clinical Microbiology, 53(12), 3834-3841. doi:10.1128/JCM.02111-15
Arnaboldi, P. M., Sambir, M., & Dattwyler, R. J. (2014). Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America. Clinical and Vaccine Immunology, 21(10), 1426-1436. doi:10.1128/CVI.00383-14
Dattwyler, R. J., & Arnaboldi, P. M. (2014). Comparison of Lyme disease serologic assays and Lyme specialty laboratories. Clinical Infectious Diseases, 59(12), 1711-1713. doi:10.1093/cid/ciu705
Klempner, M. S., Baker, P. J., Shapiro, E. D., Marques, A., Dattwyler, R. J. , Halperin, J. J., & Wormser, G. P. (2014). The reply. American Journal of Medicine, 127(2), E11-112. doi:10.1016/j.amjmed.2013.09.029
Signorino, G., Arnaboldi, P. M., Petzke, M. M., & Dattwyler, R. J. (2014). Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease. Clinical and Vaccine Immunology, 21(5), 704-711. doi:10.1128/CVI.00792-13
Arnaboldi, P. M., Seedarnee, R., Sambir, M., Callister, S. M., Imparato, J. A., & Dattwyler, R. J. (2013). Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early Lyme disease. Clinical and Vaccine Immunology, 20(4), 474-481. doi:10.1128/CVI.00608-12
Klempner, M. S., Baker, P. J., Shapiro, E. D., Marques, A., Dattwyler, R. J., Halperin, J. J., . . . Wormser, G. P. (2013). Treatment trials for post-Lyme disease symptoms revisited. American Journal of Medicine, 126(8), 665-669. doi:10.1016/j.amjmed.2013.02.014
